EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases

Janik Grothues, Jendrik Hardes, Abbas Agaimy, Stephane Collaud, Lars Podleska, Farhad Farzalyev, Nina Myline Engel, Rainer Hamacher, Benjamin Fletcher, Christoph Pöttgen, Stefanie Bertram, Hans-Ulrich Schildhaus und 3 weitere

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05980-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Janik Grothues und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Oncology, Sarcoma Center, 45147, Essen, Germany. Hauptthemen laut MEDLINE: Sarcoma, Clear Cell. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Blueprint Medicines, Novartis, Incyte, Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Clear cell sarcoma (CCS) of tendons and aponeuroses and CCS-like malignant gastrointestinal neuroectodermal tumor/sarcoma (GINET) are characterized by frequent local and distant relapses, alongside with low efficacy of all systemic treatments. We aimed to collect a comprehensive dataset to identify prognostic factors and treatment outcomes.

Methods

We performed a retrospective single center analysis for diagnosed CCS and GINET on demographic, tumor, treatment and survival data.

Results

We identified 43 patients (w:25, m:18) with a median follow-up of 35mo and a 5y-OS-rate of 42%. At diagnosis the median age was 42yrs. Median tumor size was 3.6 cm (0.3–11.1 cm), and 24/26 (94%) tissues analyzed at our institute were EWSR1::ATF1 -translocation-positive. Distant extremities (incl. knee or elbow) were affected in 72.5%. Of note, 79.5% received an excisional biopsy (benign histology suspected in 30.2%) leading to frequent incomplete resection. Final R0 status correlated significantly (p = 0.017) with longer survival rates compared to R + status in localized CCS (N0M0, 5-yr OS 0% vs 64%). Radiation and systemic treatment had limited antitumor effects while isolated limb perfusion was active in some patients. 18.6% of patients showed lymphatic spread and 20.9% distant metastases. Presence of initial M + was associated with a dismal survival of 1.4 years (M +) vs 7.1 years (M0; p < .001).

Conclusion

We here present one of the largest clinical cohorts of patients with CCS/GINET. Our data underscores the exceptional risk of metastatic disease even in small tumors. As systemic treatment and radiation showed limited efficacy, complete resection was the most important treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, Clear CellHumansMaleFemaleAdultRetrospective StudiesMiddle AgedPrognosisAgedYoung AdultAdolescentSoft Tissue NeoplasmsSurvival Rate

Stichwörter der Autor:innen

CCSClear cell sarcomaEWSR1Gastrointestinal sarcomaMalignant melanoma of soft tissuePrognostic factors

Autor:innen und Institutionen

  • Department of Musculoskeletal Oncology, Sarcoma Center, 45147, Essen, Germany.
  • German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital, Erlangen, Germany.
  • Lung Clinic, Department of Thoracic Surgery, Cologne Merheim Hospital, University of Witten/Herdecke, Witten, Germany.
  • Department of Medical Oncology and Sarcoma Center, West German Cancer Center, Medical School, University Duisburg-Essen, Essen, Germany.
  • Department of Radiotherapy, West German Cancer Centre, University Hospital Essen, 45147, Essen, Germany.

Förderung

  • Blueprint Medicines, Novartis, Incyte
  • Universitätsklinikum Essen

Zitieren

APA

Grothues, J., Hardes, J., Agaimy, A., Collaud, S., Podleska, L., Farzalyev, F., Engel, N. M., Hamacher, R., Fletcher, B., Pöttgen, C., Bertram, S., Schildhaus, H. U., Streitbürger, A., Bauer, S., & Falkenhorst, J. (2024). Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05980-3

Vancouver

Grothues J, Hardes J, Agaimy A, Collaud S, Podleska L, Farzalyev F, et al. Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05980-3

BibTeX
@article{Grothues2024,
  author = {Grothues, Janik and Hardes, Jendrik and Agaimy, Abbas and Collaud, Stephane and Podleska, Lars and Farzalyev, Farhad and Engel, Nina Myline and Hamacher, Rainer and Fletcher, Benjamin and Pöttgen, Christoph and Bertram, Stefanie and Schildhaus, Hans-Ulrich and Streitbürger, Arne and Bauer, Sebastian and Falkenhorst, Johanna},
  title = {Prognostic factors in clear cell sarcoma: an analysis of soft tissue sarcoma in 43 cases},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05980-3}
}
Kostenlos starten →